The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial

Dose dependent augmentation of neuroplasticity-based auditory learning in schizophrenia: a double-blind, placebo-controlled, randomized, target engagement clinical trial of the N-methyl-D-aspartate-type glutamate receptor (NMDAR) agonist d-serine

(2023) Pejman Sehatpour et al.   BIOLOGICAL PSYCHIATRY

Quantitative electroencephalography parameters as neurophysiological biomarkers of schizophrenia-related deficits: A Phase II substudy of patients treated with iclepertin (BI 425809)

(2022) Christian Schultheis et al.   Translational Psychiatry

Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials

(2019) Chun-Hung Chang et al.   JOURNAL OF PSYCHOPHARMACOLOGY

40-Hz auditory steady-state responses and the complex information processing: An exploratory study in healthy young males

(2019) Vykinta Parciauskaite et al.   PLoS One

Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms

(2018) J. Ferri et al.   PSYCHOLOGICAL MEDICINE

Delta Vs Gamma Auditory Steady State Synchrony in Schizophrenia

(2017) Krishna C Puvvada et al.   SCHIZOPHRENIA BULLETIN

Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain

(2017) Vinita Jagannath et al.   Frontiers in Neuroanatomy

Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms

(2017) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

The dose makes the poison: from glutamate-mediated neurogenesis to neuronal atrophy and depression

(2016) Alberto Rubio-Casillas et al.   REVIEWS IN THE NEUROSCIENCES

Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia

(2016) Laura M. Rowland et al.   JAMA Psychiatry

Effects of NMDA and GABA-A Receptor Antagonism on Auditory Steady-State Synchronization in Awake Behaving Rats

(2015) E. M. Sullivan et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Biological insights from 108 schizophrenia-associated genetic loci

(2014)   NATURE

Add-on Treatment of Benzoate for Schizophrenia

(2013) Hsien-Yuan Lane et al.   JAMA Psychiatry

Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia

(2011) Surendra P. Singh et al.   CNS DRUGS

High dose D-serine in the treatment of schizophrenia

(2010) Joshua T. Kantrowitz et al.   SCHIZOPHRENIA RESEARCH

Secretin Effects on Cerebellar-Dependent Motor Learning in Schizophrenia

(2009) Amanda R. Bolbecker et al.   AMERICAN JOURNAL OF PSYCHIATRY

Investigation of G72 (DAOA) expression in the human brain

(2009) Isabel Benzel et al.   BMC Psychiatry

The neurobiology of D-amino acid oxidase and its involvement in schizophrenia

(2009) L Verrall et al.   MOLECULAR PSYCHIATRY

Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine

(2009) L Elliot Hong et al.   NEUROPSYCHOPHARMACOLOGY

Eye-blink conditioning deficits indicate temporal processing abnormalities in schizophrenia

(2009) Amanda R. Bolbecker et al.   SCHIZOPHRENIA RESEARCH

Cerebellum and Detection of Sequences, from Perception to Cognition

(2008) Marco Molinari et al.   CEREBELLUM

Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia

(2008) Caroline Madeira et al.   SCHIZOPHRENIA RESEARCH